X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-Apparently-To: jeeproject@yahoo.com via 72.30.238.183; Wed, 06 Nov 2013 15:01:12 +0000
Return-Path: <info@updates.f1000.com>
Received-SPF: pass (domain of updates.f1000.com designates 81.92.113.103 as permitted sender)
X-YMailISG: VfTVNscWLDsKHdGLjkNRCVcd0QI.hLKsgET6mzVRs.JznuFB
 x2LVfwG7O2YNCHXOoI5qqh4OrUsSud_xKngIkwpFzYY8ycmK1uDrfKsEOY4E
 XT4rhIW.ZH9IGcCsuFcqe5pdzL_kgDYPCdh3gtJsJoEfkIF_2B0E9SUU7Ry3
 PLNSAoHy5Tuz5Lm_e7dviy2gBGHg60cUiImxdYPI3fEw2Riu_rIu5sNuVARj
 QHCteZ4bE27tmG8TUMuyvghMqzOROgYG6_TfnOZL32v3KXbMXSzPJ4LP0jMz
 q0Xuvapbtr1MPu29mLY78.PfCsyRHQ.xcZbGzEG9J2T7sr7dcLhO66Aat2UE
 maI6ng4sf6mTlXNvSNGiX3PbnGbjsfnb_.7ebHFE127lkPMDE9WnNCrNYTNb
 mxEESZmEeIlUcLGknx.14j3waKLKGGXFFAv71Eql77YLyBMdGxNzu6nVuxtY
 DFJ.Ti.ks1l9i1U7uoyB.9kv6iKgx9yVUDB01jsT.Hp5HrSuLoaVMaMLTxoi
 cYp8F1rH.pE9p08R2EnHnnqV9dJe2ROrtBrC2owEPU0jG89s3AhYc6YWl6CI
 W_NrESVAYbxPVqaqpqpatzcDoQDHfS0ela.LLvVBPxfetVhmi.WMn3Rk8lPR
 QliA4Qz9Z9INPmBNw09Cotv3Enu8J3IzZe6ihe2emS2kvpG0ImgVOL1.xe0s
 TA7.lNNG9CBMBM4d7bpjOo7n0etz5SUQVAnK5JcvwTo9k9WQlZhu.0LrD5g4
 K27ChTBaWryQN9UiGlVURHCoEwuIoFuspuP02qUbKuMPLS_rp6biq4sRK2O3
 epMoQJOlcg0hCzqxfa3YNA5DFtAJoT7KeI9GEyoUZjj0RWGhJvYeUByPeifa
 vGAe.FTStT7q83OB60Diji826k7wdUzBM5i5kXfCWnXLMlW.ceEB6y85NVVy
 Qk6S59xk_td02syZju4tdcqW6vrIpw.bANfxMLDwqWnipoI7OJ7KnYJloaa3
 nbSIJsn6BZ4TupVirK2uZiYa2dg7E8wSIQac3xvmWZMizaHLp5.je4.kZvw2
 do2JMzBjPcvwUIzjD5EYJ9uJ82Yqm4J1.TjNoD065aBPG0NSw2FajQN30aIk
 5BZ_8mjo6e6SlxImlGUnrnCKlB6OUCi3RxPaXbLza9g2BsJu2WOtZ7W9cJ2h
 _SnJv6K5Ip76KB0q7Qp_fGBdSHDXLKHoFGDwW3Rsl6vM2wyei9HtEezqJTzY
 PUxUQelfLagXHe9JIG9105iuAhpXwSfcZ6B.gCN3_0JvjwQ3A7ZzeDr4.6xQ
 gg5O8SYsb_qViU4jhEvuAF8hdwH3luopJn8NMbFP_7WrVe3FxzHTFz39BnOS
 SLQ2jze2u6yuoYYXjhs3xqGrGpqo_E87ONeJh9WKdv0Wjr0tvzsmNuzBj2eb
 sPtgX1MuD0_RC2D8IfphiDlHwb2KZwlEAC4r4boLynnY2eKzZQz1Hw27deIw
 CU8AJVeypa2oFoKi4Rrco.ObTI2PpVMFgAxFgp2uOKcKBIb09BRimiuVVMrG
 cLXsPHeNyZKTN4fI
X-Originating-IP: [81.92.113.103]
Authentication-Results: mta1216.mail.ne1.yahoo.com  from=updates.f1000.com; domainkeys=neutral (no sig);  from=updates.f1000.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO emailer113-103.emv5.com) (81.92.113.103)
  by mta1216.mail.ne1.yahoo.com with SMTP; Wed, 06 Nov 2013 15:01:11 +0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=emv; d=updates.f1000.com;
 h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type:List-Unsubscribe; i=info@updates.f1000.com;
 bh=582n1JYC+47EkS/XRwM6b3zrBAg=;
 b=WxQJohaPw0hL3UulIT0wa21wUG1qtmhU3RcodjLMJPD2YkhDwVE+Eg8a9U8VpgMGxYwMp5YuevP1
   tRqKDsDdGQUbCPxyvv8qkxNl8jqTIv0T773uLaEMBFvwTyPwkCw7+3/M3YeYK0x61Fr8CJWfdXDn
   iEddX/hzpzyqXEKt/SI=
Received: by emailer113-103.emv5.com id hf9cre167583 for <jeeproject@yahoo.com>; Wed, 6 Nov 2013 15:57:59 +0100 (envelope-from <info@updates.f1000.com>)
Return-Path: info@updates.f1000.com
Date: Wed, 6 Nov 2013 15:57:59 +0100 (CET)
From: Faculty of 1000 <info@updates.f1000.com>
Reply-To: Faculty of 1000 <info@f1000.com>
To:  <jeeproject@yahoo.com>
Message-ID: <2.1.4.1101019921.2311134.807521937@updates.f1000.com>
Subject: Gain of function, loss of pain: November's monthly picks
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary=2311134807521937
X-EMV-Platform: p4ccc.campaigncommander.com$
X-EMV-CampagneId: 2311134$
X-EMV-MemberId: 807521937$
List-Unsubscribe: <http://p4trc.emv2.com/HD?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYXBfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLh>, <mailto:unsubscribe@updates.f1000.com?subject=unsubscribe-4-ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYXBfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLh>
Content-Length: 64521

--2311134807521937
Content-Type: text/plain; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

To ensure you receive emails from Faculty of 1000, add info@updates.f1000.com to your safelist.

-----------------------------------------------------

Faculty of 1000 | http://f1000.com         
Monthly Update  |  November 2013     

-----------------------------------------------------

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
 F1000Prime gets personal         
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
We've introduced a new personalized homepage [ http://blog.f1000.com/2013/10/22/new-prime-homepage/ ] and email alert for all users of F1000Prime. Anyone can now create a highly personalized feed of articles recommended in F1000Prime, as well as new articles in PubMed, based on their own research interests. These new F1000Prime features are, for a limited time, freely available for a one-month personal trial to any individual who registers with F1000Prime [ http://f1000.com/prime/signin ].

All new and returning users of F1000Prime are invited to attend a free, live online demonstration [ http://blog.f1000.com/2013/10/25/attend-an-online-demonstration/ ] of the new features of F1000Prime. Find out more and register for a live demonstration here [ http://f1000prime.eventbrite.co.uk/ ].

 ---------------
 Attend a live demo
 > > http://f1000prime.eventbrite.co.uk  
 ---------------


  F1000Prime                             
==================

1,384 recommendations  [ http://f1000.com/prime/search/evaluations ] added in the past month. Below is a selection:

Gain, but no pain   
[ http://f1000.com/prime/718109968?key=nfcVk6cwEYxXGkh ]       
That a gain-of-function mutation in a channel expressed in nociceptor neurons leads to reduced pain sensation is, at first glance, very unexpected.
Leipold E, Liebmann L, Korenke GC et al.    
Nat Genet. 2013 Nov; 45:1399-404   


HIV vulnerability window    
[ http://f1000.com/prime/718106971?key=Q9i063B4JHKKYKB ]       
The first few hours to days of HIV or SIV infection is hypothesized as the window of vulnerability for the virus, which may have implications for prevention.
Hansen SG, Piatak M, Ventura AB et al.
Nature. 2013 Oct 3; 502:100-4

Potent anthrax antibiotic discovered  
[ http://f1000.com/prime/718056131?key=1NKc8UtLulRzFxU ]     
Though many new antibiotics are identified every year, truly structurally new antibiotics are rarely discovered, and this one is important for countering bioterrorism.
Jang KH, Nam SJ, Locke JB et al.
Angew Chem Int Ed Engl. 2013 Jul 22; 52:7822-4

* F1000Prime Reports *

Open-access review journal [ http://f1000.com/prime/reports/ ], reporting on the hottest topics.     

The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference? 
[ http://f1000.com/prime/reports/m/5/50/ ]     
Increased and earlier use of azathioprine seems to reduce surgery rates in inflammatory bowel disease.
F1000Prime Report by Vivek Chhaya and Richard Pollok [ http://f1000.com/prime/thefaculty/member/3467337218310302 ].
F1000Prime Rep 2013, 5:39

 ---------------
 See all recent F1000Prime Reports          
 >> http://f1000.com/prime/reports/                 
 ---------------   
 


   F1000Research                      
======================

Our innovative open access journal [ http://f1000research.com/ ] offering rapid publication, open peer review and open data.

Below is a selection of our latest peer reviewed articles:   

COMMENTARY      
Advancing the activity cliff concept [ http://f1000research.com/articles/2-199/v1 ] [v1; ref status: indexed, http://f1000r.es/1wf [ http://f1000r.es/1wf ]]
Published: 30 Sep 2013        
Hu Y, Stumpfe D, Bajorath J.       
F1000Research 2:199       

REVIEW     
Did the elimination of lead from petrol reduce crime in the USA in the 1990s? [ http://f1000research.com/articles/2-156/v2 ] [v2; ref status: indexed, http://f1000r.es/220 [ http://f1000r.es/220 ]]   
Latest Published: 08 Oct 2013      
Hall W.     
F1000Research 2:156     
  
SHORT RESEARCH ARTICLE      
Novel targets of miR-30, a microRNA required for biliary development [ http://f1000research.com/articles/2-197/v1 ] [v1; ref status: indexed, http://f1000r.es/1so [ http://f1000r.es/1so ]]     
Published: 24 Sep 2013     
Le Guen CL, Friedman JR, Hand NJ.    
F1000Research 2:197   


----------------------------------------------
 Submit now to F1000Research          
 >> http://f1000research.com/author/submit        
----------------------------------------------

~~~~~~~~~~
 Neuroscience meeting and data plotting tool   
 > > http://f1000research-sfn13-mu.eventbrite.com/
~~~~~~~~~~

We will be at the Society for Neuroscience meeting in San Diego, where we'll show you an exciting new feature of F1000Research that will allow you to interact in a new way with the data in our papers. You can find out more at our booth (222) at the exhibit or join us for a free drink at our reception on Mon 11 Nov. To attend the reception (also open to local researchers), register here [ http://f1000research-sfn13-mu.eventbrite.com/ ].

    
   F1000Trials                     
==================

A comprehensive listing [ http://f1000.com/trials ] of clinical trial articles reviewed by the F1000 Faculty, with the most important tagged as recommended.

Below is a taster of F1000Trials content. To read, please sign-in [ http://f1000.com/trials/signin ] or register for free [ http://f1000.com/trials/register ]: 

Key to male vitality?      
[ http://f1000.com/trials/718106470?key=VO0mcidk4j8Xs2w ]   
Testosterone isn't the 'be all and end all' in men. Estrogen is shown to play a larger than expected role in body tone, strength and sexual function.
Finkelstein JS, Lee H, Burnett-Bowie SA et al.    
N Engl J Med. 2013 Sep 12; 369:1011-22    

Smoking gun for colon cancer  
[ http://f1000.com/trials/717996345?key=er5qbvZizM2MycY ]    
A phase III trial shows that smoking is significantly associated with less disease-free survival and time to recurrence of colon cancer.   
Phipps AI, Shi Q, Newcomb PA et al.   
J Clin Oncol. 2013 Jun 1; 31:2016-23   

Hypnobirthing ineffective 
[ http://f1000.com/trials/718052146?key=y8AyONdv97jFXDH ]     
Proof from an RCT that antenatal hypnosis training does not lessen labor pain nor the amount of labor analgesia required during childbirth.    
Cyna A, Crowther C, Robinson J et al. 
BJOG. 2013 Sep; 120:1248-59   

    
    F1000Posters                 
======================
 
Open Repository [ http://f1000.com/posters ] for posters and slide presentations; completely free to view and submit. Below are a few selections:

* NEUROSCIENCE *    

Looking at faces from different angles: Europeans fixate on different features in Asian and Caucasian faces   
[ http://f1000.com/posters/browse/summary/1094378 ]
Brielmann A, BÜlthoff I, Armann R.  
F1000Posters 2013, 4:1163  

* ECOLOGY *

The Stonehenge landscape: restoring biodiversity and connectivity      
[ http://f1000.com/posters/browse/summary/1094414 ]
Twiston-Davies G, Mitchley J, Mortimer S.    
F1000Posters 2013, 4:1145   

* PSYCHIATRY *

Metabolic parameters and risk for psychosis in adolescent 
[ http://f1000.com/posters/browse/summary/1094416 ]    
Demro C, Kline E, Bussell K et al.   
F1000Posters 2013, 4:1185   

----------------------------------------------
 Deposit now        
 >> http://f1000.com/posters/fordepositors      
---------------------------------------------- 
 
  
----------------------

 * F1000Tips *

Follow @F1000Tips on Twitter [ http://twitter.com/f1000tips ] for tips, tricks, and customer support for all Faculty of 1000 service:

@F1000 | https://twitter.com/f1000   
@F1000Trials | http://twitter.com/f1000trials  
@F1000Research | http://twitter.com/f1000research   
@F1000Posters | http://twitter.com/f1000posters 
  
---------------------- 
 
-----------------------------------------------------   

In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).

You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may unsubscribe [ http://www.f1000.com/unsubscribe/email?email=jeeproject@yahoo.com&emailAlertType=MONTHLY_UPDATES ] at any time. For further information or enquiries please contact Customer Services at info@f1000.com [ mailto:info@f1000.com ].

Faculty of 1000 Ltd | Science Navigation Group
Registered in England and Wales with Company Number 3739756
Middlesex House, 34-42 Cleveland Street | London, W1T 4LB | United Kingdom

--2311134807521937
Content-Type: text/html; charset=iso-8859-15
Content-Transfer-Encoding: 8bit

<html><!--"Multipart/Alternative MIME" format-->
<style type="text/css">
	.footer a, .footer a:visited { color:#CCCCCC;}
	blockquote .hide-forwarded {display: none !important;}
</style>
	<body leftmargin="0" marginwidth="0" topmargin="0" marginheight="0" offset="0">
		<table width="100%" border="0" cellpadding="0" cellspacing="0">
			<tr>
				<td>
					<table width="640" align="center" border="0" cellpadding="0" cellspacing="0" >
						<!-- BEGIN Header -->
							<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td colspan="5" style="text-align:center;color:#666;font-family:arial,sans-serif;font-size:11px;">
								<strong style="font-weight:bold;">To ensure you receive F1000 emails, add <a style="color:#CB2D2D; text-decoration: none;" href="mailto:info@updates.f1000.com">info@updates.f1000.com</a> to your safelist.<br>If this email is not displaying properly, please <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HM?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhbGsvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlHf">view in your usual browser</a>.</strong>							</td>
					  </tr>
						<tr>
							<td width="5" colspan="5" style="background-color: #FFF">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5">
							</td>
						</tr>
						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrQPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKQ"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/12-1843_LSD_2D_468x60_Banner_Ad.jpg" style="display:block;"width="468" height="60" border="0" alt=""/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
						</tr>

						<tr>
							<td width="1" style="background-color: #CCC">
								<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1">
							</td>
							<td colspan="3">
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<!-- BEGIN Network Bar -->
									<tr>
										<td colspan="3" width="100%">
											<table style="background-color: #222222;" border="0" cellpadding="0" cellspacing="0" width="640">
												<tr>
													<td width="10" height="30">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="10" height="1" style="display:block;">
													</td>
													<td width="80">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrQfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKR" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000prime.gif" width="80" height="30" border="0">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="76">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrRvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKW" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000trials.gif" width="76" height="30" border="0">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="102">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrR_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKX" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000research.gif" width="102" height="30" border="0">
														</a>
													</td>
													<td width="35">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
													<td width="91">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrRPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKU" style="color:#FFF;font:bold 11px Arial,sans-serif;text-decoration:none;">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/f1000posters.gif" width="91" height="30" border="0">
														</a>
													</td>
													<td width="176">
														<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" width="35" height="1" style="display:block;">
													</td>
												</tr>
											</table>
										</td>
									</tr>
									<!-- END Network Bar -->
									<!-- BEGIN Header Image -->
									<tr>
										<td colspan="3" width="640" height="70">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrRfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKV"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/monthly_update_email_header_grey.gif" border="0" width="640" height="70" title="F1000 Monthly Update Email Header" alt="F1000 Monthly Update Email Header" style="display:block;"/></a>
										</td>
									</tr>
									<!-- END Header Image -->
								</table>
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Header -->
						<!-- BEGIN Content -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Left Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="478">
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="15"></td>
									</tr>
									<!-- BEGIN Date and Intro -->
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:18px;">
											November 2013
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:bold; color:#383838;font-family:'arial bold',sans-serif;font-size:14px;">
											F1000Prime gets personal
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									 <tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="5" style="font-weight:normal; color:#383838;font-family:'arial bold',sans-serif;font-size:12px;">We've introduced a new <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrWvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKa" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">personalized homepage</a> and email alert for all users of F1000Prime. Anyone can now create a  highly personalized feed of articles  recommended in F1000Prime, as well as new articles in PubMed, based on their  own research interests. These new F1000Prime features are, for a limited  time, freely available for a one-month personal trial to any individual who <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrW_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKb" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">registers with F1000Prime</a>. <br><br>
									    All new and returning users of F1000Prime are invited to <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrWPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKY" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">attend  a free, live online demonstration</a> of the new features  of F1000Prime. Find out more and register for a live demonstration <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrWfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKZ" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">here</a>.<br><br>
                                        <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrXvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKe"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Demo-Button.gif" border="0" style="display:block;"width="175" height="35"></a></td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    <tr>
										<td width="20" colspan="7" style="background-color: #FFF; "><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<!-- END Date and Intro --> 
									<tr>
										<td width="20" colspan="7" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="220">
												<!-- BEGIN Prime -->
												<tr>
													<td style="background-color: #CB2D2D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrX_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKf">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_prime.jpg" border="0" style="display:block;"width="220" height="75">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
                                                    
                                                    
														<strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrXPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKc" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;">1,384 recommendations</a> added in the past month. Below is a selection:</strong>
												  </td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrXfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKd">Gain, but no pain</a><br />
														That a gain-of-function  mutation in a channel expressed in nociceptor neurons leads to reduced pain  sensation is, at  first glance,  very unexpected.<br>
Leipold E, Liebmann L, Korenke GC <em>et al</em>. <em>Nat Genet</em>. 2013 Nov; 45:1399-404
<div>
  <div> </div>
</div></td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrUvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKi">HIV vulnerability window</a><br />
														The first few hours to days  of HIV or SIV infection is hypothesized as the window of vulnerability for the  virus,  which may have implications for prevention.<br>														Hansen SG, Piatak M, Ventura AB <em>et al</em>.<br>
														<em>Nature</em>. 2013 Oct 3; 502:100-4</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrU_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKj">Potent anthrax antibiotic discovered</a><br />
														Though  many new antibiotics are identified every year, truly structurally new  antibiotics are rarely discovered, and this  one is important for countering bioterrorism.
                                                        <br>
                                                        Jang KH,&nbsp;Nam SJ,&nbsp;Locke JB<em> et al</em>.<br>
                                                        <em>Angew Chem Int Ed Engl</em>. 2013 Jul 22; 52:7822-4</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:14px;">
														<strong style="font-weight:bold;">F1000Prime Reports</strong>
													</td>
												</tr>
												<tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                <tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><strong><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrUPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKg" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;">Open-access review journal</a>, reporting on the hottest topics.</strong></td>
												</tr>
                                                
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												  <tr>
													<td width="220" height="103">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrUfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKh"><img src="http://f1000.com/prime/reports/m/5/50/feature-thumbnail.jpg" alt="F1000Prime Reports" width="220" style="display:block;" title="kinase inhibitors" border="0"/></a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<a style="font-weight:bold; color:#CB2D2D;text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrVvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKm">The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?</a><br />
														Increased  and earlier use of azathioprine seems to reduce surgery rates in inflammatory  bowel disease.<br />
														<em>F1000Prime Report</em> by Vivek Chhaya and <a style="color:#CB2D2D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrV_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKn">Richard Pollok</a>.
													<br>
													<em>F1000Prime Rep</em> 2013, <strong>5</strong>:39<br><br>
                                                    <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrVPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKk" style="font-weight:bold; color:#CB2D2D;font-family:arial,sans-serif;font-size:12px;text-decoration:none;">See all recent <em>F1000Prime Reports</em>.</a></td>
											  	</tr>
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Prime -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Research -->
												<tr>
													<td style="background-color: #CB622D">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrVfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKl">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_research.jpg" border="0" style="display:block;"width="220" height="75">
														</a>
													</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<strong>Our innovative <a style="font-weight:bold; color:#CB622D; text-decoration: none;"href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYravcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKq">open access journal</a> offering rapid publication, open peer review and open data.<br>
                                                  <br>
                                                  Below is a selection of our latest peer reviewed articles:</strong></td>
										    </tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">COMMENTARY</span><br />
												  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYra_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKr">Advancing the activity cliff concept</a> [v1;  ref status: indexed, <a  style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYraPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKo">http://f1000r.es/1wf</a>]<br />
									          			Published: 30 Sep 2013<br />
									          			Hu Y, Stumpfe D, Bajorath J<em>.</em><br>
									          			<em>F1000Research</em> <strong>2</strong>:199</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><span style="font-family: arial, sans-serif; color: #999">REVIEW</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrafcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKp">Did the elimination of lead from petrol reduce crime in the USA in the 1990s?</a> [v2; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrbvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKu">http://f1000r.es/220</a>]<br />
											      		Latest Published: 08 Oct 2013<br />
											      		Hall W.<br />
														<em>F1000Research</em> <strong>2:</strong>156</td>
												</tr>
												<tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999;">SHORT RESEARCH ARTICLE</span><br />
													  	<a style="font-weight:bold; color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrb_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKv">Novel targets of miR-30, a microRNA required for biliary development</a> [v1; ref status: indexed, <a style="color:#CB622D; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrbPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKs">http://f1000r.es/1so</a>]<br />
														Published: 24 Sep 2013<br />
														Le Guen CL, Friedman JR, Hand NJ<em>.</em><br>
												        <em>F1000Research</em> <strong>2</strong>:197
												    </td>
												</tr>
												
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="15"></td>
												</tr>
                                                <tr>
													<td width="30" colspan="3" style="background-color: #FFF"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrbfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKt" style="text-decoration:none; color:#CB622D;"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Submit-Now.gif" alt="Submit Now" width="136" height="27" border="0" style="display:block;" title="Submit your article" heigt="30"/>	</td>
												</tr>
                                                
                                                <tr>
													<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td bgcolor="#CB622D" style="color:#FFFFFF;font-family:arial,sans-serif;font-size:12px; padding: 5px"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrYvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKy" style="font-weight:bold; color:#FFF;font-family:arial,sans-serif;font-size:12px;text-decoration:none;">&gt;&gt; Neuroscience meeting and data plotting tool</a></td>
											  </tr>
                                              <tr>
													<td style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
											  </tr>
                                              <tr>
													<td style="background-color: #FFF"></td>
											  </tr>
                                              
												<tr>
													<td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">We will be at the Society for Neuroscience meeting in San Diego, where we'll show you an exciting new feature of <em>F1000Research</em> that will allow you to interact in a new way with the data in our papers. You can find out more at our booth (222) at the exhibit or join us for a free drink at our reception on Mon 11 Nov. To attend the reception (also open to local researchers), <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrY_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKz" style="color:#CB622D; text-decoration: none;">register here</a>.</td>
											  </tr>
												<tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="5"></td>
												</tr>
                                                <tr>
                                                <td align="center"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrYPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKw"><img src="http://webr.emv2.com/faculty1000/flying-man_eToC_img.gif" width="151" height="126"></a></td>
                                                </tr><tr>
													<td width="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
												<!-- END Research -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="1" colspan="7" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>
									<tr>
										<td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Trials -->
																								
                                                <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
                                                
<tr>
					  <td colspan="3" style="background-color: #2d8acb"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrYfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlKx"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/header_trials.jpg" border="0" style="display:block;"width="220" height="75"></a></td>
							    </tr>
                                 <tr>
													<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
                                <tr>
                                  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style=" color:#2D8ACB; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrZvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK2"><strong>A comprehensive listing</strong></a><strong> of clinical trial articles reviewed by the F1000  Faculty, with the most important tagged as recommended.</strong></td>
											  </tr>
                                
                                                <tr>
                                                  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
                                                
                                                
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Below is a taster of F1000Trials content. To read, please <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrZ_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK3" style="font-weight:bold; color:#2D8ACB; text-decoration:none" >sign-in</a> or <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrZPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK0" style="font-weight:bold; color:#2D8ACB; text-decoration:none" >register for free</a>:</td>
												</tr>
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              <tr>
                                                <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrZfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK1">Key to male vitality?</a><br />
                                                  Testosterone isn't the 'be all and  end all' in men. Estrogen is shown to play a  larger than expected role in body tone, strength and sexual function.<br>
                                                Finkelstein JS, Lee H, Burnett-Bowie SA <em>et al</em>. <em>N Engl J Med</em>. 2013 Sep 12; 369:1011-22</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
                                              
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrevcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK6">Smoking gun for colon cancer</a><br />
												    A phase III trial shows that smoking is  significantly associated with less disease-free survival and time to recurrence  of colon cancer.<br>
                                                  Phipps AI, Shi Q, Newcomb PA  <em>et al</em>. <br><em>J Clin Oncol</em>. 2013 Jun 1; 31:2016-23</td>
											  </tr>
                                              <tr>
                                                <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<tr>
												  <td style="color:#383838;font-family:arial,sans-serif;font-size:12px;"><a style="font-weight:bold; color:#2D8ACB; text-decoration: none;" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYre_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK7">Hypnobirthing ineffective</a><br>
												    Proof from an RCT that antenatal  hypnosis training does not lessen  labor pain nor the amount of labor analgesia required  during childbirth.<br>
												    Cyna A, Crowther C, Robinson J <em>et al</em>. 
                                                  <em>BJOG</em>.  2013 Sep; 120:1248-59</td>
											  </tr>
                                              
                                              
												<tr>
												  <td width="20" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
											  </tr>
												<!-- END Trials -->
											</table>
										</td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
										<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
										<td valign="top">
											<table border="0" cellpadding="0" cellspacing="0" width="218">
												<!-- BEGIN Posters -->
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="10"></td>
												</tr>
													<tr>
													<td colspan="3" style="background-color: #733380">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrePcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK4">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/heading_posters.jpg" border="0" style="display:block;"width="220" height="75">														</a>													</td>
												</tr>
												<tr>
													<td width="80" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" width="20"></td>
												</tr>
												
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<strong>	<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrefcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK5" style="text-decoration:none; color:#733380;">Open Repository</a> for posters and slide presentations; completely free to view and submit.  Below is a selection:</strong>													</td>
											  </tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="30"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color:#999; font-family:arial,sans-serif;">NEUROSCIENCE</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrfvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK-"><img src="http://cdn.f1000.com/posters/thumbnails/256884126" border="0" width="80" heigt="95" title="poster_1" alt="poster_1" style="display:block;"/></a> </td>
													<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td width="132" valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a  style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrf_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK_">Looking at faces from different angles: Europeans fixate on different features in Asian and Caucasian faces</a></td>
												</tr>
												
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><span style="font-family: arial, sans-serif; font-size: 12px; color: #383838">Brielmann  A, B&uuml;lthoff I, Armann R.<br>
F1000Posters 2013, <strong>4</strong>:1163</span></td>
												</tr>
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">ECOLOGY</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrfPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK8"><img src="http://cdn.f1000.com/posters/thumbnails/256829732" alt="Poster 2" width="80" height="57" style="display:block;" title="Poster 2" border="0" heigt="113"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrffcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlK9">The Stonehenge landscape: restoring biodiversity and connectivity</a></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><span style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Twiston-Davies  G, Mitchley J, Mortimer S.<br>
F1000Posters 2013, <strong>4</strong>:1145</span></td>
												</tr>
                                                
                                                <tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
														<span style="color: #999; font-family: arial, sans-serif;">PSYCHIATRY</span></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
												</tr>
												<tr>
													<td valign="top" width="80" heigt="128">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrcvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLC"><img src="http://cdn.f1000.com/posters/thumbnails/256860359" alt="Poster 2" width="80" height="60" style="display:block;" title="Poster 2" border="0" heigt="114"/></a>													</td>
														<td width="8" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="8"></td>
												  <td valign="top" style="color:#383838;font-family:arial,sans-serif;font-size:12px;">
													<a style="font-weight:bold; color:#733380; text-decoration:none" href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrc_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLD">Metabolic parameters and risk for psychosis in adolescent</a></td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><span style="color:#383838;font-family:arial,sans-serif;font-size:12px;">Demro  C, Kline E, Bussell K <em>et al</em>.<br>
F1000Posters 2013, <strong>4</strong>:1185</span></td>
												</tr>
                                                
                                                <tr>
													<td height="20" colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<tr>
													<td colspan="3" heigt="20">
														<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrcPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLA">
															<img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/Deposit-Now.gif" border="0" width="136" heigt="27" title="Deposit Now" alt="Deposit a Poster" style="display:block;"/>														</a>													</td>
												</tr>
												<tr>
													<td colspan="3" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="20"></td>
												</tr>
												<!-- END Posters -->
											</table>
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>	
								</table>
							</td>
							<!-- END Left Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
							<!-- BEGIN Right Content Column -->
							<td valign="top">
								<table border="0" cellpadding="0" cellspacing="0" width="159">
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" heigt="22">
											<!-- BEGIN Share Widget -->
											<a href="http://p4trc.emv2.com/HSL?lang=us&a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLJ3zyvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlCh"><img src="http://p4trc.emv2.com/dispatcher/images/share/swmn01a.gif" border="0" align="absmiddle" title="Share this email"></a>
											<!-- END Share Widget -->
										</td>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
									
									
									
									<tr>
										<td colspan="4" heigt="600">
										    <!-- begin ad tag 160x600  ad slot size -->
											 <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrcfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLB"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/12-1843_LSD_2D_160x600_Banner_Ad.jpg" style="display:block;"width="160" height="600" border="0" alt=""/></a>
											<!-- End ad tag 160x600  ad slot size -->
										</td>
									</tr>
									<tr>
										<td colspan="4" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
									</tr>
                                    
                                    
                                     <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td colspan="4" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
				          <!-- END News Section -->
									
									 <tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="font-weight:bold;color:#383838;font-family:arial,sans-serif;font-size:14px;"><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrdvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLG"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/F1000tips.gif" alt="F1000Tips" border="0" style="display:block;" width="139" height="139"></a></td>
								  	  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    <tr>
										<td height="10" colspan="4" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
									<tr>
										<td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
										<td colspan="2" style="color:#383838;font-family:arial,sans-serif;font-size:11px;">Follow <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrd_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLH" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">@F1000Tips</a> on  Twitter for tips, tricks, and customer support for all Faculty of 1000 services:<br><br>
                                      <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrdPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLE" style="font-weight:bold; color:#CB2D2D; text-decoration: none;">@F1000</a>, <br><a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrdfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLF" style="font-weight:bold; color:#2d8acb; text-decoration: none;">@F1000Trials</a>, <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrCvcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLK" style="font-weight:bold; color:#CB622D; text-decoration: none;">@F1000Research</a>, <a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrC_cStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLL" style="font-weight:bold; color:#733380; text-decoration: none;">@F1000Posters</a></td>
									  <td width="10" style="background-color: #FFF"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="10"></td>
									</tr>
                                    
                                    
                                    
                                    
				          <!-- END of twitter section -->
                                    
								
                                    
								</table>
                                
                                
                                
							</td>
							<!-- END Right Content Column -->
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>
						</tr>
						<!-- END Content -->
						<!-- BEGIN Footer -->
						<tr>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
							<td colspan="3">
								<!-- BEGIN 468x60 ad slot -->
								<table border="0" cellpadding="0" cellspacing="0" width="100%">
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;" height="1"></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="15" /></td>
									</tr>
									<tr>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
										<td width="468" height="60">
											<a href="http://p4trc.emv2.com/HS?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrCPcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLI"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/12-1843_LSD_2D_468x60_Banner_Ad.jpg" style="display:block;"width="468" height="60" border="0" alt=""/></a>
										</td>
										<td width="86" height="60"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="60" /></td>
									</tr>
									<tr>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
										<td  width="468" style="text-align:right;color:#999;font-family:arial,sans-serif;font-size:10px;">
											ADVERTISEMENT
										</td>
										<td width="86"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="86" height="10" /></td>
									</tr>
									<tr>
										<td colspan="3" width="100%"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="100%" height="8" /></td>
									</tr>
									<tr>
										<td height="1" colspan="3" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"height="1"></td>
									</tr>	
								</table>
								<!-- END 468x60 ad slot -->
							</td>
							<td width="1" style="background-color: #CCC"><img src="http://webr.emv2.com/faculty1000/F1000_Monthly_images/spacer.gif" style="display:block;"width="1"></td>	
						</tr>
						<!-- END Footer -->
						<!-- BEGIN Footer -->
						<tr>
							<td colspan="5">
								<table border="0" cellpadding="0" cellspacing="10" style="background: #222222; border:1px solid #ccc;" width="100%">
									<tr>
										<td style="color:#CCCCCC;font-family:arial,sans-serif;font-size:11px;">
											In addition to this Monthly Update, we also send out emails featuring deals and discounts for registered users. To sign up, registered users should visit MyF1000 via any F1000 product and opt-in to receive "Information from F1000 about special offers" (under Email Alerts).<br><br>
											<span class="hide-forwarded">You have received this message because you asked to receive the F1000 Monthly Update to your registered email address from Faculty of 1000. If you do not wish to receive any further such messages, you may <a href="http://p4trc.emv2.com/HP?a=ENX7CqkWrP9-8SA9MKJsmCTnGHxKLhYrCfcStGb5lw8W0bBhOG5mpqVsje_HhdBmMlLJ" style="color:#CCCCCC;text-decoration:none;" target="_blank"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>unsubscribe</b></font></a> at any time. </span>For further information or enquiries please contact Customer Services at <a href="mailto:info@f1000.com" style="color:#CCCCCC;text-decoration:none;"><font color="#CCCCCC" font-size="2" face="arial,sans-serif"><b>info@f1000.com</b></font></a>.<br /><br />
											Faculty of 1000 Ltd &#124; Science Navigation Group<br>
											<b>Registered in England and Wales with Company Number 3739756</b><br>
											Middlesex House, 34-42 Cleveland Street &#124; London, W1T 4LB &#124; United Kingdom
										</td>
									</tr>
								</table>
							</td>
						</tr>
						<!-- END Footer -->
					</table>
				</td>
			</tr>
		</table>
	<img src="http://p4trc.emv2.com/HO?DdX7CqkWrP9-8SA9MOPv4OvnGHxKLL6wFAjtS5kGR0KyKyM.gif" border="0" alt="" width="1" height="1" /></body>
</html>
--2311134807521937--

